HT
SUPN icon

Headlands Technologies’s Supernus Pharmaceuticals SUPN Stock Holding History

Headlands Technologies’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,473
Closed -$1.12M – 961
2025
Q4 		$1.12M Buy
22,473
+17,861
+387% +$868K 0.09% 251
2025
Q3 		$220K Buy
+4,612
New +$186K 0.02% 524
2025
Q1 		– Sell
-1,515
Closed -$54.8K – 1511
2024
Q4 		$54.8K Buy
1,515
+1,015
+203% +$35.7K 0.01% 796
2024
Q3 		$15.6K Sell
500
-6,007
-92% -$187K ﹤0.01% 976
2024
Q2 		$174K Buy
+6,507
New +$189K 0.02% 509

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return